Pulmonary Embolism and COVID-19 (COVID-19-PE)

Uşak University

Status: Unknown

Conditions: Pulmonary Embolism; Covid-19

Treatments: Other: intensive care unit admission ratio

Study type: Observational

Funder types: Other

Identifiers

NCT04590378

UU-PE001

Details and patient eligibility

About

The charts of patients who developed pulmonary embolism in the course of COVID-19 will be evaluated, retrospectively. Clinical features and laboratory data will be analyzed.

Full description

Patients with COVID-19 infection will be evaluated retrospectively. Demographic data, clinical and laboratory findings will be recorded. Findings of patients with pulmonary embolism and withour pulmonary embolism will be compared.

Enrollment: 600 estimated patients

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• All patients with positive RT-PCR for COVID-19

Exclusion criteria

• All patients with negative RT-PCR for COVID-19

Trial design

600 participants in 2 patient groups

Covid-19 Patients with Pulmonary embolism

Description:

Clinically demonstared cases infected with COVID-19 who developed pulmonary embolism.

Treatment:

Other: intensive care unit admission ratio

Covid-19 Patients without Pulmonary embolism

Description:

Clinically demonstared cases infected with COVID-19 who did not develop pulmonary embolism.

Treatment:

Other: intensive care unit admission ratio